{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:05:16Z","timestamp":1787169916851,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>There is a strong relationship between arterial stiffness and endothelial dysfunction and hypertension. How arterial stiffness is affected in elevated PRL conditions is uncertain. Biological action of prolactin contributing to the atherosclerotic process is a new research area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>We aimed at investigating cardiovascular risk predictability by conducting arterial stiffness measurement in patients with idiopathic hyperprolactinemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>The biochemical parameters and arterial stiffness analyses of 54 patients with idiopathic hyperprolactinemia, who had applied to our polyclinic in 2017 and 2018, and 55 healthy volunteers having similar characteristics with regard to age, sex and body mass index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The median prolactin level of the idiopathic hyperprolactinemia patients with a median age of 31 was found to be 45 ng\/mL. The peripheral and central blood pressures and pulse wave velocities (PWV) of both the patient group and the control group were found to be similar. Any relations between prolactin levels and blood pressure and arterial stiffness could not be found.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Our study showed that arterial stiffness did not increase in young patients with idiopathic mild hyperprolactinemia. However, the long-term effects of mildly elevated prolactin levels are unknown. Prospective randomized studies are required, that could reveal more clearly the prolactin-cardiovascular risk relation, and the clinical effects of extra-pituitary hyperprolactinemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_178_20","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T02:55:50Z","timestamp":1692586550000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Is Idiopathic Mild Hyperprolactinemia a Cardiovascular Risk Factor?"],"prefix":"10.4103","volume":"24","author":[{"given":"AO","family":"Koca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Da\u011fdeviren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Akkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Keskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Pamuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Altay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2007-0017","article-title":"What can we learn from rodents about prolactin in humans?","volume":"29","author":"Ben-Jonathan","year":"2008","journal-title":"Endocr Rev"},{"key":"R2-11-20240907","first-page":"104","article-title":"Update in prolactinomas","volume":"68","author":"Kars","year":"2010","journal-title":"Neth J Med"},{"key":"R3-11-20240907","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Endocrine society. Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-11-20240907","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1160\/TH05-09-0634","article-title":"Enhanced platelet activation by prolactin in patients with ischemic stroke","volume":"96","author":"Wallaschofski","year":"2006","journal-title":"Thromb Haemost"},{"key":"R5-11-20240907","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1210\/jc.2008-0305","article-title":"Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes","volume":"93","author":"Lea\u00f1os-Miranda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-11-20240907","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/HYPERTENSIONAHA.109.132100","article-title":"Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors","volume":"54","author":"Georgiopoulos","year":"2009","journal-title":"Hypertension"},{"key":"R7-11-20240907","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1490187","article-title":"Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women","volume":"149","author":"Yavuz","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"R8-11-20240907","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ajh.2011.16","article-title":"Pilot study of circulating prolactin levels and endothelial function in men with hypertension","volume":"24","author":"Stamatelopoulos","year":"2011","journal-title":"Am J Hypertens"},{"key":"R9-11-20240907","doi-asserted-by":"crossref","first-page":"e002640","DOI":"10.1161\/JAHA.115.002640","article-title":"Association between prolactin and incidence of cardiovascular risk factors in the Framingham heart study","volume":"5","author":"Therkelsen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R10-11-20240907","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.atherosclerosis.2012.01.017","article-title":"Sex-specific associations of serum prolactin concentrations with cardiac remodeling: Longitudinal results from the Study of Health Pomerania (SHIP)","volume":"221","author":"Haring","year":"2012","journal-title":"Atherosclerosis"},{"key":"R11-11-20240907","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.06840711","article-title":"Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD","volume":"7","author":"Carrero","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-11-20240907","first-page":"181","article-title":"Endocrine alterations and cardiovascular risk in CKD: Is there a link?","volume":"33","author":"Ros","year":"2013","journal-title":"Nefrologia"},{"key":"R13-11-20240907","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/jhh.2017.15","article-title":"Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause","volume":"31","author":"Georgiopoulos","year":"2017","journal-title":"J Hum Hypertens"},{"key":"R14-11-20240907","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/138161209787354249","article-title":"Is there any additional prognostic value of central blood pressure wave forms beyond peripheral blood pressure?","volume":"15","author":"Sabovic","year":"2009","journal-title":"Curr Pharm Des"},{"key":"R15-11-20240907","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/HYPERTENSIONAHA.109.133116","article-title":"Large and small artery cross-talk and recent morbidity-mortality trials in hypertension","volume":"54","author":"Laurent","year":"2009","journal-title":"Hypertension"},{"key":"R16-11-20240907","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/HJH.0000000000000021","article-title":"Pathophysiology of hypertension: Interactions between macro and microvascular alterations through endothelial dysfunction","volume":"32","author":"Yannoutsos","year":"2014","journal-title":"J Hypertens"},{"key":"R18-11-20240907","doi-asserted-by":"crossref","first-page":"IV31","DOI":"10.1161\/01.CIR.0000133442.99186.39","article-title":"Surrogate markers for cardiovascular disease: Functional markers","volume":"109","author":"Cohn","year":"2004","journal-title":"Circulation"},{"key":"R19-11-20240907","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0032-1333232","article-title":"Macroprolactinemia in patients with prolactinomas: Prevalence and clinical significance","volume":"121","author":"Elenkova","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R20-11-20240907","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(77)90701-2","article-title":"Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension","volume":"2","author":"Lewis","year":"1977","journal-title":"Lancet"},{"key":"R21-11-20240907","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/HJH.0b013e328339f254","article-title":"Plasma prolactin level and risk of incident hypertension in postmenopausal women","volume":"28","author":"Zhang","year":"2010","journal-title":"J Hypertens"},{"key":"R22-11-20240907","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcp.1041480116","article-title":"Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanism","volume":"148","author":"Sauro","year":"1991","journal-title":"J Cell Physiol"},{"key":"R23-11-20240907","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/labinvest.3700256","article-title":"Prolactin stimulates integrin-mediated adhesion of circulating mononuclear cells to endothelial cells","volume":"85","author":"Montes de Oca","year":"2005","journal-title":"Lab Invest"},{"key":"R24-11-20240907","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.intimp.2005.04.002","article-title":"Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes\/macrophages","volume":"5","author":"Malaguarnera","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"R25-11-20240907","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/en.2006-1577","article-title":"Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms","volume":"148","author":"Molinari","year":"2007","journal-title":"Endocrinology"},{"key":"R26-11-20240907","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCGENETICS.109.853572","article-title":"Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women","volume":"2","author":"Reuwer","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"R27-11-20240907","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/bmj.4.5999.738","article-title":"Influence of age on serum prolactin levels in women and men","volume":"4","author":"Vekemans","year":"1975","journal-title":"Br Med J"},{"key":"R28-11-20240907","first-page":"761","article-title":"Prolactin pulsatile characteristics in postmenopausal women","volume":"83","author":"Katznelson","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-11-20240907","first-page":"1083","article-title":"Mechanisms subserving the physiological nocturnal relative hypoprolactinemia of healthy older men: Dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency, and interpulse interval--a general clinical research center study","volume":"84","author":"Iranmanesh","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-11-20240907","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygcen.2015.02.001","article-title":"Extra-pituitary prolactin (PRL) and prolactin-like protein (PRL-L) in chickens and zebrafish","volume":"220","author":"Bu","year":"2015","journal-title":"Gen Comp Endocrinol"},{"key":"R31-11-20240907","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12020-017-1346-x","article-title":"Prolactin function and putative expression in the brain","volume":"57","author":"Cabrera-Reyes","year":"2017","journal-title":"Endocrine"},{"key":"R32-11-20240907","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/me.2013-1349","article-title":"Minireview: Extrapituitary prolactin: An update on the distribution, regulation, and functions","volume":"28","author":"Marano","year":"2014","journal-title":"Mol Endocrinol"},{"key":"R33-11-20240907","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2265.2006.02469.x","article-title":"The influences of hyperprolactinemia and obesity on cardiovascular risk markers: Effects of cabergoline therapy","volume":"64","author":"Serri","year":"2006","journal-title":"Clin Endocrinol (Oxf"},{"key":"R34-11-20240907","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4158\/EP15938.DSC","article-title":"Amer\u0131can Assoc\u0131at\u0131on of Cl\u0131n\u0131cal Endocr\u0131nolog\u0131sts, Amer\u0131can College of Endocr\u0131nology D\u0131sease State Cl\u0131n\u0131cal Rev\u0131ew: Cl\u0131n\u0131cal relevance of macroprolactin in the absence or presence of true hyperprolactinemia","volume":"21","author":"Samson","year":"2015","journal-title":"Endocr Pract"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_178_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:55Z","timestamp":1787166895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_178_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_178_20","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}